Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Cerilliant
Mallinckrodt
Healthtrust
Citi
Daiichi Sankyo
Chinese Patent Office
Cantor Fitzgerald
UBS
McKinsey

Generated: January 23, 2018

DrugPatentWatch Database Preview

OXYCODONE AND ASPIRIN Drug Profile

« Back to Dashboard

When do Oxycodone And Aspirin patents expire, and what generic alternatives are available?

Oxycodone And Aspirin is a drug marketed by Actavis Labs Fl Inc, Mayne Pharma Inc, Sun Pharm Industries, Watson Labs, and Roxane. and is included in six NDAs.

The generic ingredient in OXYCODONE AND ASPIRIN is aspirin; oxycodone hydrochloride; oxycodone terephthalate. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the aspirin; oxycodone hydrochloride; oxycodone terephthalate profile page.

US Patents and Regulatory Information for OXYCODONE AND ASPIRIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride TABLET;ORAL 090084-001 Mar 22, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride; oxycodone terephthalate TABLET;ORAL 087794-001 May 26, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mayne Pharma Inc OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride TABLET;ORAL 091670-001 Mar 16, 2011 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride; oxycodone terephthalate TABLET;ORAL 040260-001 Jul 17, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane OXYCODONE AND ASPIRIN (HALF-STRENGTH) aspirin; oxycodone hydrochloride; oxycodone terephthalate TABLET;ORAL 087742-001 Jun 4, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs OXYCODONE AND ASPIRIN aspirin; oxycodone hydrochloride; oxycodone terephthalate TABLET;ORAL 040255-001 Feb 27, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
US Department of Justice
Cerilliant
McKesson
Farmers Insurance
UBS
Cantor Fitzgerald
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot